Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Wound Care

PUBLISHER: Grand View Research | PRODUCT CODE: 1433590

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1433590

U.S. And Latin America Chronic Wound Care Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

U.S. And Latin America Chronic Wound Care Market Growth & Trends:

The U.S. And Latin America chronic wound care market size is anticipated to reach USD 8.23 billion by 2030 and is anticipated to expand at a CAGR of 4.11% during the forecast period, according to a new report by Grand View Research, Inc. Steep rise in the number of hospitals & urgent care centers and an increase in hospital admissions. Moreover, rapid advancements in chronic wound care and the increasing number of ambulatory surgical centers (ASCs) are key contributors to the U.S. & Latin America chronic wound care market growth.

The increasing number of ambulatory surgical centers (ASCs), is expected to boost the market growth over the forecast period. ASCs provide patients with precise guidance related to dressings and post-surgical home care. Alongside this, ASCs enjoy advantageous reimbursement coverage for their services, which increases their adoption, leading to a decreased risk of patients contracting post-surgical infections typically associated with hospital stays. Consequently, as the number of ASCs and the volume of surgeries conducted continue to rise, the demand for wound care products is expected to increase. For instance, as per the report of Blue House Sales Group, in August 2023, there were about 6,179 Medicare-certified ASCs present in the U.S. These factors are expected to boost the U.S. & Latin America chronic wound care market growth over the forecast period.

The increasing product launch and strategic collaboration by key market players in the chronic wound care market is one of the major drivers for the market. For instance, in January 2023, Convatec launched the ConvaFoam in the U.S. ConvaFoam is a family of advanced foam dressings designed to meet the demands of medical professionals and their patients. Moreover, in March 2022, Convatec Group completed the acquisition of Triad Life Sciences Inc. to enter the wound biologics segment. These factors, as mentioned above, are expected to propel market growth over the forecast period.

U.S. And Latin America Chronic Wound Care Market Report Highlights:

  • Based on the product, the advanced wound dressing segment dominated the market in 2023 with the largest share owing to the increasing cases of diabetes
  • On the basis of application, the diabetic foot ulcers segment dominated the market in 2023. Increasing incidence of diabetes and diabetic foot ulcers is a major factor driving the segment growth
  • The hospital's segment held the largest share of the overall end-use market in 2023 owing to the growing incidence of chronic wounds, an increase in the number of surgeries, and a rise in the aging population
  • U.S. dominated the overall market with the highest revenue share in 2023 owing to technological advancements and the growing incidence of chronic conditions in the region
Show more
Product Code: GVR-4-68040-186-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. & Latin America Chronic Wound Care Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
      • 3.2.1.2. Introduction of innovative and advanced wound products
      • 3.2.1.3. Rising geriatric population
      • 3.2.1.4. Increasing number of ambulatory surgical centers (ASCs)
      • 3.2.1.5. Steep rise in the number of hospitals & urgent care centers and an increase in hospital admissions
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent manufacturing policies
      • 3.2.2.2. High cost of advanced wound care products and chronic wound treatments
    • 3.2.3. Market opportunity analysis
  • 3.3. U.S. & Latin America Chronic Wound Care Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Covid-19 Impact Analysis

Chapter 4. U.S. & Latin America Chronic Wound Care Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Advanced wound dressing
    • 4.1.2. Surgical wound care
    • 4.1.3. Traditional wound care
    • 4.1.4. Wound therapy devices
  • 4.2. Product Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. U.S. & Latin America Wound Care Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
    • 4.5.1. Advanced wound dressing
      • 4.5.1.1. Advanced wound dressing market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.2. Foam dressings
      • 4.5.1.2.1. Foam dressings market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.3. Hydrocolloid dressings
      • 4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.4. Film dressings
      • 4.5.1.4.1. Film dressings market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.5. Alginate dressings
      • 4.5.1.5.1. Alginate dressings market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.6. Hydrogel dressings
      • 4.5.1.6.1. Hydrogel dressings market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.7. Collagen dressings
      • 4.5.1.7.1. Collagen dressings market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.8. Other advanced dressings
      • 4.5.1.8.1. Other advanced dressings market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Surgical wound care
      • 4.5.2.1. Surgical wound care market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.2. Sutures & staples
      • 4.5.2.2.1. Sutures & staples market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.3. Tissue adhesives & sealants
      • 4.5.2.3.1. Tissue adhesives & sealants market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.4. Anti-infective dressing
      • 4.5.2.4.1. Anti-infective dressing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Traditional wound care
      • 4.5.3.1. Traditional wound care market estimates and forecast 2018 to 2030s, (USD Million)
      • 4.5.3.2. Medical tapes
      • 4.5.3.2.1. Medical tapes market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.3.3. Cleansing agents
      • 4.5.3.3.1. Cleansing agents market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.3.4. Others
      • 4.5.3.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Wound therapy devices
      • 4.5.4.1. Wound therapy devices market estimates and forecast 2018 to 2030s, (USD Million)
      • 4.5.4.2. Negative pressure wound therapy
      • 4.5.4.2.1. Negative pressure wound therapy market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.4.3. Oxygen and hyperbaric oxygen equipment
      • 4.5.4.3.1. Oxygen and hyperbaric oxygen equipment market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.4.4. Electric stimulation devices
      • 4.5.4.4.1. Electric stimulation devices market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.4.5. Pressure relief devices
      • 4.5.4.5.1. Pressure relief devices market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.4.6. Others
      • 4.5.4.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. U.S. & Latin America Chronic Wound Care Market: Application Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Diabetic foot ulcers
    • 5.1.2. Pressure ulcers
    • 5.1.3. Venous leg ulcers
    • 5.1.4. Other chronic wounds
  • 5.2. Application Market Share, 2018 & 2030
  • 5.3. Segment Dashboard
  • 5.4. U.S. & Latin America Wound Care Market by Application Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
    • 5.5.1. Diabetic foot ulcers
      • 5.5.1.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Pressure ulcers
      • 5.5.2.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Venous leg ulcers
      • 5.5.3.1. Venous leg ulcers market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.4. Other chronic wounds
      • 5.5.4.1. Other chronic wounds market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. U.S. & Latin America Chronic Wound Care Devices: End-use Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Hospitals
    • 6.1.2. Specialty clinics
    • 6.1.3. Home healthcare
    • 6.1.4. Others
  • 6.2. End-use Market Share, 2018 & 2030
  • 6.3. Segment Dashboard
  • 6.4. U.S. & Latin America Wound Care Market by End-use Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Hospitals
      • 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Specialty clinics
      • 6.5.2.1. Specialty clinics market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Home healthcare
      • 6.5.3.1. Home healthcare market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Others
      • 6.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. U.S. & Latin America Chronic Wound Care Market: Regional Estimates & Trend Analysis

  • 7.1. Regional market share analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2023
    • 7.4.1. North America
    • 7.4.2. Latin America
  • 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
  • 7.6. North America
    • 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. U.S.
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement scenario
      • 7.7.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 7.7.2. Mexico
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Mexico market estimates and forecasts, 2018 - 2030
    • 7.7.3. Colombia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Colombia market estimates and forecasts, 2018 - 2030
    • 7.7.4. Panama
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. Panama market estimates and forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
  • 8.6. Company Profiles
    • 8.6.1. Smith & Nephew PLC
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. Molnlycke Health Care AB
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. ConvaTec Group PLC
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. Baxter International
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Coloplast Corp.
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. Medtronic
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. 3M
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. Derma Sciences (Integra LifeSciences)
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. Medline Industries, Inc.
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives
    • 8.6.10. 3M
      • 8.6.10.1. Company overview
      • 8.6.10.2. Financial performance
      • 8.6.10.3. Product benchmarking
      • 8.6.10.4. Strategic initiatives
    • 8.6.11. Ethicon (Johnson & Johnson)
      • 8.6.11.1. Company overview
      • 8.6.11.2. Financial performance
      • 8.6.11.3. Product benchmarking
      • 8.6.11.4. Strategic initiatives
    • 8.6.12. B. Braun SE
      • 8.6.12.1. Company overview
      • 8.6.12.2. Financial performance
      • 8.6.12.3. Product benchmarking
      • 8.6.12.4. Strategic initiatives
    • 8.6.13. Cardinal Health, Inc.
      • 8.6.13.1. Company overview
      • 8.6.13.2. Financial performance
      • 8.6.13.3. Product benchmarking
      • 8.6.13.4. Strategic initiatives
    • 8.6.14. Organogenesis Inc
      • 8.6.14.1. Company overview
      • 8.6.14.2. Financial performance
      • 8.6.14.3. Product benchmarking
      • 8.6.14.4. Strategic initiatives
    • 8.6.15. MIMEDX Group, Inc.
      • 8.6.15.1. Company overview
      • 8.6.15.2. Financial performance
      • 8.6.15.3. Product benchmarking
      • 8.6.15.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-186-7

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 US chronic wound care market, by product, 2018 - 2030 (USD Million)
  • Table 4 US chronic wound care, by application, 2018 - 2030 (USD Million)
  • Table 5 US chronic wound care market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 Latin America chronic wound care market, by country, 2018 - 2030 (USD Million)
  • Table 7 Latin America chronic wound care market, by product, 2018 - 2030 (USD Million)
  • Table 8 Latin America chronic wound care market, by application, 2018 - 2030 (USD Million)
  • Table 9 Latin America chronic wound care market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Brazil chronic wound care market, by product, 2018 - 2030 (USD Million)
  • Table 11 Brazil chronic wound care market, by application, 2018 - 2030 (USD Million)
  • Table 12 Brazil chronic wound care market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Mexico chronic wound care market, by product, 2018 - 2030 (USD Million)
  • Table 14 Mexico chronic wound care market, by application, 2018 - 2030 (USD Million)
  • Table 15 Mexico chronic wound care market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Colombia chronic wound care market, by product, 2018 - 2030 (USD Million)
  • Table 17 Colombia chronic wound care market, by application, 2018 - 2030 (USD Million)
  • Table 18 Colombia chronic wound care market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Panama chronic wound care market, by product, 2018 - 2030 (USD Million)
  • Table 20 Panama chronic wound care market, by application, 2018 - 2030 (USD Million)
  • Table 21 Panama chronic wound care market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 US & Latin America chronic wound care market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Segment Outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Consumer behavior analysis
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Market opportunities relevance analysis (Current & future impact)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTLE (political & legal, economic and technological) analysis
  • Fig. 19 US & Latin America chronic wound care market: product movement analysis
  • Fig. 20 Segment dashboard
  • Fig. 21 US & Latin America chronic wound care market product outlook: Key takeaways
  • Fig. 22 Advanced wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 23 Foam dressings market, 2018 - 2030 (USD Million)
  • Fig. 24 Hydrocolloid dressings market, 2018 - 2030 (USD Million)
  • Fig. 25 Film dressings market, 2018 - 2030 (USD Million)
  • Fig. 26 Alginate dressings market, 2018 - 2030 (USD Million)
  • Fig. 27 Hydrogel dressings market, 2018 - 2030 (USD Million)
  • Fig. 28 Collagen dressings market, 2018 - 2030 (USD Million)
  • Fig. 29 Other advanced dressings market, 2018 - 2030 (USD Million)
  • Fig. 30 Surgical wound care market, 2018 - 2030 (USD Million)
  • Fig. 31 Sutures & staples market, 2018 - 2030 (USD Million)
  • Fig. 32 Tissue adhesives and sealants market, 2018 - 2030 (USD Million)
  • Fig. 33 Anti-infective dressing market, 2018 - 2030 (USD Million)
  • Fig. 34 Traditional wound care market, 2018 - 2030 (USD Million)
  • Fig. 35 Medical tapes market, 2018 - 2030 (USD Million)
  • Fig. 36 Cleansing agents market, 2018 - 2030 (USD Million)
  • Fig. 37 Others market, 2018 - 2030 (USD Million)
  • Fig. 38 Wound therapy devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Negative pressure wound therapy market, 2018 - 2030 (USD Million)
  • Fig. 40 Oxygen and hyperbaric oxygen equipment market, 2018 - 2030 (USD Million)
  • Fig. 41 Electric stimulation devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Pressure relief devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Others market, 2018 - 2030 (USD Million)
  • Fig. 44 US & Latin America chronic wound care market: end-use movement analysis
  • Fig. 45 Segment dashboard
  • Fig. 46 US & Latin America chronic wound care market End-use outlook: Key takeaways
  • Fig. 47 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 48 Specialty clinics market, 2018 - 2030 (USD Million)
  • Fig. 49 Home healthcare market, 2018 - 2030 (USD Million)
  • Fig. 50 Others market, 2018 - 2030 (USD Million)
  • Fig. 51 US & Latin America chronic wound care market: Application movement analysis
  • Fig. 52 Segment dashboard
  • Fig. 53 US & Latin America chronic wound care market application outlook: Key takeaways
  • Fig. 54 Diabetic foot ulcers market, 2018 - 2030 (USD Million)
  • Fig. 55 Pressure ulcers market, 2018 - 2030 (USD Million)
  • Fig. 56 Venous leg ulcers market, 2018 - 2030 (USD Million)
  • Fig. 57 Regional outlook, 2018 & 2030
  • Fig. 58 Regional market dashboard
  • Fig. 59 Regional market place: Key takeaways
  • Fig. 60 US chronic wound care market, by product, 2018 - 2030 (USD Million)
  • Fig. 61 US chronic wound care market, by application, 2018 - 2030 (USD Million)
  • Fig. 62 US chronic wound care market, by end-use, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America chronic wound care market, by country, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America chronic wound care market, by product, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America chronic wound care market, by application, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America chronic wound care market, by end-use, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil chronic wound care market, 2018 - 2030 (USD Million)
  • Fig. 68 Mexico chronic wound care market, 2018 - 2030 (USD Million)
  • Fig. 69 Colombia chronic wound care market, 2018 - 2030 (USD Million)
  • Fig. 70 Panama chronic wound care market, 2018 - 2030 (USD Million)
  • Fig. 71 Key Company Categorization
  • Fig. 72 Company Market Positioning
  • Fig. 73 Key Company Market Share Analysis, 2023
  • Fig. 74 Strategic Framework
  • Fig. 75 Regional network map
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!